Log In
Print this Print this

metatinib (BL001)

  Manage Alerts
Collapse Summary General Information
Company Beijing Labsolutions Pharmaceuticals Co. Ltd.
DescriptionBCR-ABL tyrosine kinase inhibitor
Molecular Target BCR-ABL tyrosine kinase (BCR-ABL)
Mechanism of ActionBCR-ABL tyrosine kinase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationLeukemia
Indication DetailsTreat leukemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today